Global Consortium Would Facilitate Early Pediatric Oncology Trials – Cmte.
Executive Summary
An international research consortium should be established to facilitate the conduct of Phase I-II trials of pediatric oncology drugs in the U.S. and other countries, members of FDA's Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee said at its July 15 meeting